Dr. Martha Mims, MD, PhD
Claim this profileBen Taub General Hospital
Studies Prostate Cancer
Studies Granulocytic Leukemia
4 reported clinical trials
22 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
Stage I
Stage II
2Granulocytic Leukemia
BCR-ABL1 positive
Philadelphia chromosome positive
Affiliated Hospitals
Clinical Trials Martha Mims, MD, PhD is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Abiraterone + Prednisone
for Prostate Cancer
The investigators are conducting this study with men that have prostate cancer and are getting standard of care treatment with the drugs abiraterone acetate and prednisone. The study will follow men with prostate cancer from initiation of participation in the study and for up to 10 years. The reason for the study is that researchers think that there may be a connection between the race and ethnicity of men with prostate cancer and how well the standard treatments work for the participants.
Recruiting1 award Phase 218 criteria
More about Martha Mims, MD, PhD
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Martha Mims, MD, PhD has experience with
- Prednisone
- Abiraterone Acetate
- Bosutinib
- Dasatinib
- Imatinib Mesylate
- Imatinib Mesylate, Dasatinib, Nilotinib Or Bosutinib Re-initiation
Breakdown of trials Martha Mims, MD, PhD has run
Prostate Cancer
Granulocytic Leukemia
Chronic Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Martha Mims, MD, PhD specialize in?
Martha Mims, MD, PhD focuses on Prostate Cancer and Granulocytic Leukemia. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are Stage I.
Is Martha Mims, MD, PhD currently recruiting for clinical trials?
Yes, Martha Mims, MD, PhD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Martha Mims, MD, PhD has studied deeply?
Yes, Martha Mims, MD, PhD has studied treatments such as Prednisone, Abiraterone Acetate, Bosutinib.
What is the best way to schedule an appointment with Martha Mims, MD, PhD?
Apply for one of the trials that Martha Mims, MD, PhD is conducting.
What is the office address of Martha Mims, MD, PhD?
The office of Martha Mims, MD, PhD is located at: Ben Taub General Hospital, Houston, Texas 77030 United States. This is the address for their practice at the Ben Taub General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.